---
title: "DC 7914 - Neoplasm, malignant, any specified part of the endocrine system"
diagnostic_code: "7914"
body_system: "Endocrine System"
cfr_section: "§ 4.119"
canonical: "https://veteranai.co/va-rating-schedule/endocrine/7914-neoplasm-malignant-any-specified-part-of-the-endocrine"
source: "https://www.ecfr.gov/current/title-38/section-4.119"
updated: "2026-07-21T05:00:59.369705Z"
---

# DC 7914 - Neoplasm, malignant, any specified part of the endocrine system

Rated under § 4.119. Body system: Endocrine System.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Neoplasm, malignant, any specified part of the endocrine system |

## Notes

- Note: A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.

# Malignant Endocrine System Neoplasm (VA Diagnostic Code 7914)

## Understanding This Condition

A malignant neoplasm of the endocrine system refers to cancer affecting any specified part of the endocrine system. The VA evaluates this condition under **Diagnostic Code 7914**, found in **§ 4.119** of the VA rating schedule for the **Endocrine System**.

## Available Rating Level

Under Diagnostic Code 7914, there is a single rating level:

| Rating | Criteria |
|--------|----------|
| **100%** | Neoplasm, malignant, any specified part of the endocrine system |

## What the VA Looks For

When rating a malignant endocrine neoplasm, the VA applies the following rules:

- **A 100 percent rating continues beyond treatment.** The 100 percent evaluation shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure.

- **A mandatory examination follows treatment.** Six months after discontinuance of such treatment, the appropriate disability rating is determined by a mandatory VA examination.

- **Changes in evaluation follow a specific process.** Any change in evaluation based upon that examination — or any subsequent examination — is subject to the provisions of § 3.105(e) of this chapter.

- **Rating on residuals.** If there has been no local recurrence or metastasis, the condition is rated on its residuals.

---

*This information is drawn directly from the VA rating schedule (§ 4.119, Diagnostic Code 7914). It is provided for general educational purposes and does not guarantee any particular rating or outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.119